Upload Avatar (500 x 500)
Yinghui Zhu
Life Science
Tongji University
Shanghai
Language: Chinese, English
Acute Leukemia
Pathogenesis
Resistance Mechanisms
Targeted Therapy
Immunotherapy
Clinical Application
High-Throughput
Proteomics
Metabolomics
Clinical Translation
Areas of Focus
- Pathogenesis and resistance mechanisms of acute leukemia
- Development of targeted immunotherapies for leukemia
Work Experience
- 2023.2 to present - Tongji University Affiliated Oriental Hospital, Translational Medicine Center; Researcher
- 2022.9 to present - School of Life Sciences and Technology / Advanced Research Institute, Tongji University; Distinguished Researcher
- 2016.3-2020 - City of Hope National Medical Center, USA; Postdoctoral Fellow/Staff Scientist
Academic Background & Achievements
- 2010.9-2016.1 PhD: Beijing Institute of Genomics, Chinese Academy of Sciences
- Selected for Shanghai Overseas High-Level Talent Plan
Publications
- Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax plus 3+7 Chemotherapy in AML, Jin J, Hou SY, Yao YY, Mao LP, Yang M, Tong HY, Zeng T, Huang JY, Zhu YH, Wang HF, 2023
- Identification of a novel NPM1 mutation in acute myeloid leukemia, Yao YY, Lin XJ, Wang C, Gu Y, Jin J, Zhu YH, Wang HF, 2023
- CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression, Murtadha M, Park M, Zhu YH, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer M, Dona AA, Vahed H, Gonzalez A, Ly K, Ouyang C, Sanchez JF, Nigam L, Chowdhury A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams JC, Pichiorri F, 2024
